Syneron Bio is a Beijing-based biotechnology company developing an AI-enabled macrocyclic peptide discovery platform, Synova
Syneron Bio is a Beijing-based biotechnology company developing an AI-enabled macrocyclic peptide discovery platform, Synova. Its closed-loop dry- and wet-lab processes support discovery of synthetic peptides, including oral cyclic peptides, cell-permeable peptides, and peptide-drug conjugates. The company is advancing a pipeline for oncology, autoimmune, metabolic, and rare diseases.